Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Aligos Therapeutics (ALGS) Asset Utilization Ratio (2021 - 2025)

Aligos Therapeutics' Asset Utilization Ratio history spans 5 years, with the latest figure at 0.02 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 72.28% year-over-year to 0.02; the TTM value through Dec 2025 reached 0.02, down 72.28%, while the annual FY2025 figure was 0.03, 15.42% down from the prior year.
  • Asset Utilization Ratio reached 0.02 in Q4 2025 per ALGS's latest filing, down from 0.04 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.21 in Q3 2023 to a low of 0.02 in Q3 2022.
  • Average Asset Utilization Ratio over 5 years is 0.07, with a median of 0.05 recorded in 2024.
  • Peak YoY movement for Asset Utilization Ratio: skyrocketed 1159.37% in 2023, then plummeted 76.19% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.02 in 2021, then skyrocketed by 506.32% to 0.11 in 2022, then plummeted by 31.7% to 0.07 in 2023, then rose by 9.82% to 0.08 in 2024, then crashed by 72.28% to 0.02 in 2025.
  • Per Business Quant, the three most recent readings for ALGS's Asset Utilization Ratio are 0.02 (Q4 2025), 0.04 (Q3 2025), and 0.04 (Q2 2025).